Cephalosporins.
D058186:Acute Kidney Injury / Q000139:chemically induced; D000743:Anemia, Hemolytic / Q000139:chemically induced; D002509:Cephaloridine / Q000627:therapeutic use*; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D002512:Cephalothin / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003875:Drug Eruptions; D004342:Drug Hypersensitivity; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D010146:Pain; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D002511:Cephalosporins; D002509:Cephaloridine; D002512:Cephalothin